Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus

PHASE3CompletedINTERVENTIONAL
Enrollment

495

Participants

Timeline

Start Date

December 31, 2006

Study Completion Date

November 30, 2007

Conditions
Post Operative Bowel Dysfunction
Interventions
DRUG

Methylnaltrexone (MOA-728)

Trial Locations (92)

1125

Budapest

2050

Camperdown

3201

Pietermaritzburg

5011

Woodville South

5112

Elizabeth Vale

7580

Cape Town

7624

Pécs

8000

Székesfehérvár

9024

Győr

10016

New York

10029

New York

11000

Beograd

12208

Albany

12401

Kingston

13210

Syracuse

13353

Berlin

15213

Pittsburgh

16132

Genova

17033

Hershey

17822

Danville

18711

Wilkes-Barre

19104

Philadelphia

20007

Washington D.C.

20052

Monza

21740

Hagerstown

22601

Winchester

22908

Charlottesville

23507

Norfolk

24040

Osio Sotto

27599

Chapel Hill

30060

Marietta

30303

Atlanta

30342

Atlanta

32901

Melbourne

32960

Vero Beach

33331

Weston

33701

St. Petersburg

34119

Naples

35128

Padua

36507

Bay Minette

36617

Mobile

37232

Nashville

38103

Memphis

40138

Bologna

40536

Lexington

43210

Columbus

43701

Zanesville

44100

Ferrara

44109

Cleveland

55104

Saint Paul

55114

Saint Paul

60068

Park Ridge

60540

Naperville

60611

Chicago

60612

Chicago

66160

Kansas City

69120

Heidelberg

70121

New Orleans

72901

Fort Smith

73104

Oklahoma City

76104

Fort Worth

76107

Fort Worth

78212

San Antonio

80262

Denver

80336

München

90033

Los Angeles

90509

Torrance

92056

Oceanside

92114

Chula Vista

92324

Colton

94304

Palo Alto

95124

San Jose

97239

Portland

97701

Bend

322224

Jacksonville

02135

Boston

02860

Pawtucket

02903

Providence

06097

Halle

00168

Roma

40-752

Katowice

31-202

Krakow

91-425

Lodz

60-355

Poznan

014461

Bucharest

020475

Bucharest

042122

Bucharest

050098

Bucharest

0084

Pretoria

0181

Pretoria

135-710

Seoul

138-736

Seoul

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT00387309 - Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus | Biotech Hunter | Biotech Hunter